Out-of-frame CBX3::ALK fusion drives ALK activation and therapy response

Area of Science:

• Oncology
• Molecular Biology
• Genetics

Background:

• Kinase gene fusions are crucial drivers of cancer and targets for precision oncology.
• Detecting functional gene fusions is essential for effective cancer treatment.

Purpose of the Study:

• To report a novel out-of-frame CBX3::ALK gene fusion in metastatic melanoma.
• To investigate the oncogenic potential and therapeutic implications of this fusion.
• To highlight limitations in current gene fusion detection strategies.

Main Methods:

• Identification of a CBX3::ALK out-of-frame fusion in a melanoma patient.
• Functional studies to assess oncogenic signaling and tumorigenic potential of fusion isoforms.
• Analysis of pan-cancer RNA sequencing and melanoma genomic datasets.

Main Results:

• The CBX3::ALK fusion produces functional ALK isoforms via alternative translation start sites.
• The patient showed a significant clinical response to the ALK inhibitor alectinib.
• Out-of-frame fusions are rare but potentially significant in cancer.

Conclusions:

• Current tertiary analysis may miss clinically relevant out-of-frame fusions.
• Alternative translation mechanisms and analytic filters (e.g., 5'/3' expression imbalance) are needed for comprehensive fusion detection.
• This finding emphasizes the importance of exploring novel fusion events in precision oncology.